Aim To determine the prevalence of long-term use by the elderly of prescribed and over-the-counter (OTC) medicines with prolonged oral clearance (POC), with regard to sugars content, dose form and therapeutic groups of medicines used. Design and setting Two cross-sectional observational surveys in ten general medical practices in north-east England during 1996. Methods Computerised patient records of all elderly patients (aged 60 years and over) were surveyed for prescribed medicines use. Within these practices, 50% of elderly patients registered with ten general medical practitioners were surveyed by postal questionnaire to assess over-the-counter (OTC) medicines use. Results Of 20,731 elderly patients registered, prevalence of use of prescribed prolonged oral clearance (POC) medicines was 9.8% (95% CI: 8.2%,11.3%) and use in females aged 75years and older was significantly more likely (P < 0.0001). Of 2,796 prescribing instances (PIs) for 143 POC medicines used long-term, 53% were gastrointestinal and 72% were sugars-free; however, 82% of 542 PIs for generic liquids were sugars-containing compared with 8% of 685 PIs for proprietary liquid oral medicines. Of 1,532 elderly respondents to a postal questionnaire, 17 were using 13 different OTC medicines with POC regularly and long-term (mean prevalence; 1.1%). Of the 17 instances of regular long-term use of OTC medicines, 59% were sugars-free. Conclusions Prescribed medicines represent the bulk of regular, long-term medicines use in the elderly. Generic prescribing is more likely to result in sugars-containing medicines being dispensed. Generic medicines manufacturers must be encouraged to provide sugars-free alternatives to POC medicines used long-term, and health professionals should be vigilant when prescribing and dispensing these medicines to the increasingly dentate elderly.
medication for chronic medical problems. The elderly consume more prescribed medication per head than any other age group: three times more than younger adults and four times more than children. In 1994, the elderly who were exempt from prescription charges were dispensed a mean of 20.7 prescription items per head. For children, a mean of 4.7 items per head, and for non-elderly adults 6.1 items per head were dispensed during the same year. 2 As the above demographic changes have occurred, improvements in dental healthcare and changes in attitudes to health and disease have led to an elderly population which is increasingly dentate. 3 Sugars in the diet remain a primary factor in dental caries aetiology. 4 The form in which sugars are presented to the oral cavity is also important. If sugars linger in the mouth and the sugarscontaining product is used regularly and long-term, then the risk to dental health is greater. 5 When medicines in liquid, syrup, or chewable tablet form contain sugar and are used long-term for the treatment of chronic disease, [6] [7] [8] [9] they pose a greater threat to dental health than those dose forms which are swallowed immediately (e.g. tablets and capsules). This increased risk is caused by the longer time taken for these dose forms to clear from the mouth compared with tablets and capsules. Prolonged oral clearance (POC) medicines are usually formulated as these dose forms for a particular reason. For example, an antacid is most efficacious in liquid form to maximise the surface area of the drug in contact with stomach acid. In addition, a liquid dose form may be used to optimise compliance of paediatric and geriatric patients with a particular medication regime where they may have difficulty in swallowing solid doses.
The sugars-free option for paediatric medicines has been well publicised in the UK, [10] [11] [12] and some community-based sugars-free medicines campaigns have had some success in limiting the use of sugars-containing medicines in children. 13, 14 However, the picture for geriatric medicines is less clear; there is no information on the extent of use of these medicines with prolonged oral clearance. In addition, it is not clear whether the impact of generic prescribing, which has been shown to increase the chance of a sugars-containing medicine being dispensed for children, 15 has a similar effect in the elderly. With these potential risk factors in mind, a study was undertaken to determine the prevalence of regular and long-term use of prescribed and over-the-counter (OTC) medicines with prolonged oral clearance, both sugars-containing and sugars-free, in the elderly. This was achieved through two surveys of elderly patients in general medical practices in north-east England.
Materials and Method
Prescribed medicines survey A survey of prescribed medicines used by the elderly was conducted in the five district health authorities of Newcastle, Gateshead, North Tyneside, South Tyneside and Northumberland. Following approval by the relevant local research ethics committees, a list of general medical practices with comprehensive computing facilities was requested RESEARCH therapeutics from each of the five health authorities. A cluster sampling technique was used for data collection, with each cluster comprising all elderly patients aged 60 years and over registered in a general medical practice. Criteria for including a practice in the survey were:
• Computerised patient medication records (PMRs) • A large list size (5000 patients or greater) • A good socioeconomic mix of patients of all ages.
Of 199 practices in the 5 districts, 125 operated comprehensive computer systems and 84 met all the inclusion criteria. Ten practices, two from each district, were chosen randomly. The senior partner at each of the 10 selected practices was contacted by letter, inviting the practice to participate in the study. Following practice agreement, arrangements were made to retrieve data for all patients aged 60 years and over registered with the practice and taking medicines with prolonged oral clearance regularly (daily or alternate day) and long-term (for 3 months or longer). Data collection was carried out in three phases between March 1996 and March 1997: in Phase 1 (March-June 1996), the computer records of all elderly patients aged 60 years and older were examined and those patients taking medicines with prolonged oral clearance were highlighted; Phase 2 (July-November 1996) involved the examination of the medication schedule for highlighted patients to collect further information on those patients taking these medicines regularly and long-term; and in Phase 3, medication and prescribing details for identified patients were entered into a relational database for subsequent analysis. The data retrieved included practice, gender and age of each patient identified and their medical problems, as well as the dose, frequency of administration and date of commencement of treatment for each POC medicine currently prescribed. The records of 100 patients (20 from each of 5 practices) were chosen randomly to quantify errors in collection, coding and entry of data. In addition, using a list of all medical and surgical products available at the time, supplied by John Richardson Computers (John Richardson Computers plc, NDC, Preston, UK), a database of all oral medicines with prolonged oral clearance was created, which included:
• Classification of the medicine according to the British National The medicines with prolonged oral clearance were coded according to dose form (i.e. liquid oral medicines, solids with prolonged oral clearance, oral gels and powders, and powders in sachets). Each prescribed medicine a patient was currently taking was recorded as a prescribing instance (PI).
A number of sources of information were used to obtain current information for the sweetening agent contained in each preparation. These were: a) The British National Formulary, 16 b) The Association of the British Pharmaceutical Industry (ABPI) Data Sheet Compendium (1995-96), 17 and c) Direct approach to medical information departments of individual pharmaceutical manufacturers. Guidelines in the British National Formulary, which advise that oral liquid preparations that do not contain fructose, glucose or sucrose can be labelled as 'sugars-free' , 16 were applied in this study.
Demographic data for England, the Northern Region and the five districts (Newcastle, North Tyneside, Gateshead, South Tyneside and Northumberland) were obtained from the Office of National Statistics. 18 The prevalence of elderly persons aged 60 years and older taking prolonged oral clearance medicines regularly and long-term was calculated by dividing the number of elderly identified in all ten practices in the five districts by the total number of elderly in this age group registered in the ten practices.
Statistical analysis was undertaken using a chi-squared test, to identify statistically significant (P < 0.05) effects of age group and gender (adjusted for age) for patients taking medicines with POC regularly and long-term.
Over the counter medicines survey
Following local research ethics committee approval, a postal questionnaire was designed with advice from the Centre for Health Services Research at the University of Newcastle. Close attention was paid to its construction and content to optimise reliability and validity. The questionnaire was then piloted with 196 patients aged 60 years and over registered with one general medical practitioner from one practice used in the prescribed medicines survey. Accompanied by a letter signed by their doctor, the questionnaire gathered information on the patient's dental status, medical conditions and medication schedule for all medicines (both prescribed and OTC) currently taken. In the pilot study, patients were asked to complete the questionnaire as well as an evaluation form which collected comments about layout, ease of reading and any difficulties in understanding the questions contained in the questionnaire.
Following statistical advice, ten general medical practitioners from the 47 included in the prescribed medicines survey (the general medical practitioner used for the pilot study was excluded from the study), were randomly sampled. Fifty per cent of each practitioner's elderly patients were then randomly sampled for inclusion in a postal questionnaire survey of OTC medicines use. Just prior to postal distribution, an enquiry was made to each participating practice to ensure that all sampled patients were still registered. Each questionnaire was accompanied by a letter signed by the patient's doctor, encouraging participation but reassuring patients that their medical care would not be affected if they declined. Freepost return envelopes were used, each of which carried an identification number relating to the patient. This number was transferred to the completed questionnaire upon receipt to ensure that the two reminders were sent only to non-respondents. In addition, all mailing included a telephone number to allow patients to contact a researcher (WB) with any query relating to the questionnaire. Data from completed questionnaires were entered into the relational database described above, along with information on the sugars content of OTC medicines, retrieved from the sources mentioned above as well as the OTC Directory -Treatments for Common Ailments. 19 From these data, the prevalence of regular and long-term use of OTC medicines with prolonged oral clearance by the elderly in the sample was determined.
Results

Prescribed medicines survey
Of the 10 practices approached at the start of the survey, 8 agreed to participate. Two stated that they were too involved in other research to be able to co-operate and therefore two further practices in the same districts were sampled randomly from the remaining practices meeting the inclusion criteria. Of the 92,570 patients of all ages registered in the 10 general medical practices surveyed, 20,371 (22%) were aged 60 years and over. Of these elderly, 3,777 (18.5%) were currently taking prescribed medicines with POC and 2,002 had been prescribed these medicines for 3 months or longer and had been taking them on a regular basis (once or alternate daily). This represented an overall prevalence of regular and long-term use of POC medicines in this elderly population of 9.8% (95% confidence intervals: 8.2%,11.3%). In 60-74-year-olds the mean prevalence was 7.8% (95% confidence intervals: 6.2%, 9.4%) and in those 75 years and older it was 13.5% (95% confidence intervals: 11.5%, 15.5%). Statistical analysis showed that females aged RESEARCH therapeutics 75 years and older were more likely to be taking medicines with prolonged oral clearance regularly and long-term than other age and gender groups (P < 0.0001).
Of the 2,002 patients taking POC medicines long-term, cardiovascular problems were recorded in 38%, and musculoskeletal and joint disorders in 24%. Overall, at the time of the survey, these elderly accounted for a total of 11,751 prescribing instances (PIs), of which 2,796 (24%) PIs were for oral medicines with POC used long-term (Table 1) . These 2,796 PIs were for 143 different medicines (Table 2) , of which 59% were liquid oral medicines accounting for 44% of the total number of long-term prescribing instances, 29% being for solids with prolonged oral clearance representing 45% of prescribing instances. Table 2 also shows the distribution of preparations and prescribing instances according to the specificity of prescribing (i.e. by proprietary or generic name); 29% of preparations but 52% of prescribing instances being for generic medicines. A relatively new dose form, the sachet, accounted for only 9% of the preparations and 10% of the total number of long-term prescribing instances, however almost all (>99%) of these PIs were for proprietary medicines.
The main therapeutic areas of use for medicines with prolonged oral clearance in the elderly were gastrointestinal medicines (36% of preparations, 53% of prescribing instances), central nervous system and cardiovascular medicines ( Figure 1) .
The sugars content of these medicines prescribed to the elderly was considered in relation to dose form and the impact of generic prescribing. Of the 143 preparations with prolonged oral clearance used long-term (Table 2) , 101 (71%) were proprietary preparations and 42 (29%) were generic preparations. However, in total, the generic preparations were available as 144 different formulations from 27 different generic manufacturers. The quality of information 16 RESEARCH therapeutics obtained from manufacturers regarding the sugars content of their medicines was variable. Generic manufacturers were prepared to state whether their formulation was sugars-free or sugars-containing but more detailed information on the amount and nature of the actual sweetening agent used was provided for only 46% of the 144 generic formulations. Proprietary manufacturers were more forthcoming and detailed information on the sweetening agents was provided for 96% of the 101 products used. The distributions of sugars-containing and sugars-free prescribing instances by dose form are shown for generic and proprietary preparations in Figure 2 . Overall, of the 2,976 prescribing instances for long-term use of POC medicines, 1,452 (52%) were for generic preparations, of which 68% were sugars-free, and 1,344 (48%) were for proprietary preparations, of which 77% were sugars-free. However, when dose forms were considered separately, the contrast was marked; 91% of the 685 proprietary PIs for liquid oral medicines were sugars-free, however, only 18% of the 542 generic PIs for liquid oral medicines were sugars-free. The majority of these sugars-containing generic medicines were laxatives. In contrast, for solids with prolonged oral clearance, which included lozenges, buccal and chewable tablets, of the 342 prescribing instances for proprietary preparations, only 43% were sugars-free, whereas 97% of the 909 prescribing instances for generic solids with POC were sugars-free (Figure 2) . The sugars-containing proprietary solids were mainly antacids formulated as chewable tablets and buccal tablets used in the prevention of angina.
The five most prescribed medicines with POC used regularly and long-term represented 66% of the total number of prescribing instances for long-term use (Table 3) . Aspirin, as a 75 mg dispersible tablet used the prevention of cardiac disease, accounted for 460 (16%) prescribing instances.
OTC medicines survey
Of the 2,322 questionnaires posted, 1029 (44.3%) were returned after the first mailing, another 308 (13%) and 324 (14%) after the first and second reminder respectively. Of the 1,661 (72%) replies, 1,532 were usable, representing an overall response rate of 66%. The telephone contact number for answering queries was used by 141 patients. Of the 1,532 respondents included in the OTC medicines survey, 57.2% were female, 67.8% were patients aged 60 to 74 years. This was very similar to the age and gender profiles of the elderly patients of the 10 general medical practices where 57.1% were female and 66.1% aged 60-74 years, suggesting that respondents were representative of the 20,371 elderly registered in the 10 practices. Of the 1,308 patients (85% of respondents) who noted a medical problem, 36% reported cardiovascular disease, 24% musculoskeletal and joint disorders.
Overall, 46% of the respondents were dentate and 32% had more than 12 natural teeth (60-74 years; 54% dentate, 75 years and older; 29% dentate). Seventy-nine patients were using OTC preparations with POC, and they accounted for 88 instances of the current use of 44 OTC preparations. Of these patients, 17 had been using OTC medicines with POC for 3 months or longer at the time of the survey (Table 4 ). This represented a mean prevalence of 1.1%. Interestingly, only three of these 17 patients reported a medical problem, none of which was related to the OTC medicine which they were taking long-term. Of the 17 instances of regular and long-term use, 53% were for liquid oral medicines and overall 59% were for sugarsfree products (Table 4) . 'Nutrition and blood' preparations, (specifically cod liver oils and tonics), represented 29% of all instances of long-term use, 80% of which were sugars-free, whereas of gastrointestinal preparations (antacids and laxatives) which represented 4 (23%) instances of use, 25% were sugars-free. All central nervous system medicines and cardiovascular system products were sugarsfree and were all effervescent or dispersible tablets; however, none of the respiratory products used long-term were sugars-free. Sucrose was the most common sweetening agent -found in five of the six 
Discussion
The use of two prevalence surveys, one of which was conducted on a sub-sample of the first, made it possible to look at overall medicines use in the elderly from all sources. This was important, since a survey concentrating purely on patient records held in general medical practice was unlikely to gain information on the use of medicines purchased over the counter from community pharmacies and other retail outlets. The information retrieved on medicines use was that reported by the elderly themselves. Overall, the response rate to this questionnaire was 66%, which was acceptable and largely representative of the elderly in the ten practices. The inclusion of a letter from the patient's general medical practitioner in the initial mailing as well as duplicate questionnaires in the two reminders helped to maximise the response rate.
It could be argued that collection of medication data directly from patients, providing it is reliable, can provide a better estimate of the actual use of medicines than information recorded on patient records in general medical practices. Patient medication records provide information on medicines prescribed, but since compliance with medication, especially in the elderly, is poor, this is of limited value in studies of medicines use. Up to 50% of the elderly may not comply with their medication and as numbers of tablets taken and dosing frequency increase, compliance with medication reduces. 21 In the OTC medicines survey, great efforts were made to simplify completion of the questionnaire to maximise its reliability. Since the OTC Survey was carried out on a subsample of the elderly surveyed in the prescribed medicines survey, it was possible to cross-check reported prescribed medicines use by respondents with actual prescribing of medicines by the general medical practitioner. This showed a high degree of reliability in reporting by OTC medicines survey respondents.
The prevalence of the use of medicines with prolonged oral clearance long-term in the elderly in 10 general medical practices in north-east England was determined to be around 9.8% for prescribed medicine use and 1.1% for OTC medicine use. These results indicated that in the Northern Region as a whole, with an elderly population of 0.62 million, 15 around 60,760 persons aged 60 years and over may have been taking prescribed medicines with prolonged oral clearance long-term at the time of the survey, with up to 6,820 elderly taking OTC medicines with POC long-term. However, the results suggest a slight overlap of these groups as 3 (18%) of the patients identified in the OTC prevalence survey were also taking a prescribed medicine with POC long-term and were identified in the prescribed medicines survey.
With regard to the sugars content of these medicines, the poor response from generic manufacturers was regrettable, as health professionals will increasingly need to consult them for essential information as generic prescribing and dispensing increases in line with government recommendations.
When all dose forms of medicines (oral, non-oral, POC and non POC) were included, a mean of 5.8 medicines per head were being used at the time of the survey for those 2,002 elderly individuals taking prescribed POC medicines long-term. It was not possible to compare this level of use with other studies since the group included in the survey was very specific and medicines use analysed by dose form has not been studied previously in the elderly. However, in the elderly population as a whole in the UK, medicine use has been recorded as 2.8 medicines per head 20 increasing significantly with age and in the institutionalised elderly. It may be that those persons requiring prolonged oral clearance medicines may be more frail than those individuals using standard solid oral dose forms such as tablets and capsules since dose forms with prolonged oral clearance are more 'user friendly' for those individuals with swallowing difficulties.
Overall, 72% of 2,796 PIs for POC medicines used long-term were sugars-free: however, only 60% of PIs for liquid oral medicines and 18% of generically prescribed oral liquids used were sugars-free. In addition, a substantial proportion (53%) of PIs for proprietary solids with POC were sugars-containing, which is of some concern as these particular dose forms are relatively new. Health professionals involved in the prescribing and dispensing to the elderly and responsible for maintaining optimal oral health in their dentate elderly patients must be made aware of these particular medicines and the risk they may present, especially in those patients who may have salivary flow compromised by concurrent use of other medications. 22 The proportion of the 1,532 respondents to the postal questionnaire who were dentate was similar to the proportions of dentate elderly found in the 1988 UK national adult dental health survey: which recorded 51% of 55-64-year-olds and 39% of 65-74-yearolds in the North as dentate. 3 Extrapolation of the results of the current study to the Northern Region as a whole indicate that as many as 8,500 elderly individuals with some natural teeth may be at risk from medicines containing sugars prescribed long-term. Although the prevalence of use of OTC medicines was lower, the proportion which were sugars-containing was higher (41%), with up to 1,286 dentate elderly in the Northern Region at risk from OTC medicines containing sugars.
General medical problems recorded in the prescribed and OTC 23 Therapeutic groups of POC medicines used long-term did not completely reflect the medical problems for which the elderly are commonly prescribed medicines in primary care. Gastro-intestinal medicines such as antacids and laxatives were used most commonly in these surveys, reflecting the nature of dose forms with prolonged oral clearance, formulated in this particular way for optimal efficacy. However, central nervous system medicines with POC were also very commonly used and this pattern of use was mainly caused by the increasing use of minor analgesics in effervescent tablet form. The vast majority of over-the-counter medicines are indicated for short-term use; pharmacists are trained to discourage patients from using them regularly and long-term. The few OTC medicines indicated for long-term use include vitamin supplements and mineral replacement products such as cod liver oil, however, 8 of the 13 OTC medicines used long-term were not indicated for long-term use. These were antacids, laxatives, cough medicines and analgesics which should be used on a 'when required' basis but were being used for periods of between 3 months and 2 years. This was of some concern since the use of OTC preparations may mask more serious conditions presenting as dyspepsia, constipation, cough and general pain. Currently, pharmacists can only monitor regular use of these OTC medicines when bought from the same pharmacy. Improving patient knowledge about the risks associated with abuse of OTC medicines is required to ensure appropriate use. The introduction of patient records of OTC medicines sales, perhaps linked to existing pharmacy systems could highlight those at risk.
The most commonly prescribed POC medicine was aspirin 75 mg dispersible tablet, its use being associated with a reduction in risk of subsequent myocardial infarction in patients with pre-existing cardiovascular disease and in primary prevention. Despite strong evidence for its benefits, it has been shown that many at risk patients do not receive aspirin on prescription, 24 however, many patients may be buying it OTC 25 and not all will be monitored by their general medical practitioner, since anecdotal evidence suggests that some patients may buy this medicine as a result of press publicity about its health benefits.
Although OTC medicines represented a small proportion of overall use of medicines with prolonged oral clearance, there is strong evidence to suggest that OTC medicine use is increasing overall, with government encouraging patients with minor ailments to visit a pharmacist before seeking advice of a general medical practitioner. 26 As a result, sales of OTC medicines in 1996 were equivalent to one-third of the NHS drugs bill. 27 In addition, since more OTC medicines are becoming available as generics, they may be more likely to contain sugars and the threat to dental health may increase.
Conclusion
Prescribed medicines with prolonged oral clearance represent the bulk of regular, long-term use of medicines with prolonged oral clearance in the elderly. Pharmaceutical manufacturers, particularly generic manufacturers must be made aware of those medicines with prolonged oral clearance likely to be used long-term and encouraged to provide sugars-free alternatives where necessary. The role of the health professional is also crucial; they should be vigilant when prescribing, dispensing and monitoring medicines with prolonged oral clearance, particularly generic medicines, as they may pose a threat to the dental health of their increasingly dentate elderly patients.
